Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 3
1998 3
1999 1
2000 2
2002 1
2003 1
2004 3
2005 2
2006 4
2007 2
2008 4
2010 7
2011 5
2012 9
2013 7
2014 17
2015 13
2016 22
2017 18
2018 14
2019 22
2020 25
2021 20
2022 12
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30830172

192 results

Results by year

Filters applied: . Clear all
Page 1
Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.
Schaefer JK, Errickson J, Li Y, Kong X, Alexandris-Souphis T, Ali MA, Decamillo D, Haymart B, Kaatz S, Kline-Rogers E, Kozlowski JH, Krol GD, Shankar SR, Sood SL, Froehlich JB, Barnes GD. Schaefer JK, et al. JAMA Intern Med. 2021 Jun 1;181(6):817-824. doi: 10.1001/jamainternmed.2021.1197. JAMA Intern Med. 2021. PMID: 33871544 Free PMC article.
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients. Steinberg BA, et al. Am J Cardiol. 2017 May 15;119(10):1590-1595. doi: 10.1016/j.amjcard.2017.02.015. Epub 2017 Mar 28. Am J Cardiol. 2017. PMID: 28363354 Free article. Clinical Trial.
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, Huber K, Jansky P, Steg PG, Hanna M, Thomas L, Wallentin L, Granger CB. Hylek EM, et al. J Am Coll Cardiol. 2014 May 27;63(20):2141-2147. doi: 10.1016/j.jacc.2014.02.549. Epub 2014 Mar 19. J Am Coll Cardiol. 2014. PMID: 24657685 Free article. Clinical Trial.
Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O, Durand E, Muñoz-García AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benítez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elízaga J, Dager A, García Del Blanco B, Ortas-Nadal Mdel R, Marsal JR, Campelo-Parada F, Regueiro A, Del Trigo M, Dumont E, Puri R, Rodés-Cabau J. Abdul-Jawad Altisent O, et al. JACC Cardiovasc Interv. 2016 Aug 22;9(16):1706-17. doi: 10.1016/j.jcin.2016.06.025. JACC Cardiovasc Interv. 2016. PMID: 27539691 Free article.
192 results